Patent details

EP3468997 Title: TREATMENT OF IGG4-RELATED DISEASES WITH ANTI-CD19 ANTIBODIES CROSSBINDING TO CD32B

Basic Information

Publication number:
EP3468997
PCT Application Number:
US2017036635
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177314119
PCT Publication Number:
WO2017214452
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF IGG4-RELATED DISEASES WITH ANTI-CD19 ANTIBODIES CROSSBINDING TO CD32B
French Title of Invention:
TRAITEMENT DES MALADIES ASSOCIÉES AUX IGG4 PAR DES ANTICORPS ANTI-CD19 SE RÉTICULANT À CD32B
German Title of Invention:
BEHANDLUNG VON ERKRANKUNGEN IM ZUSAMMENHANG MIT IGG4 MIT ANTI-CD19-ANTIKÖRPERN MIT KREUZBINDUNG AN CD32B
SPC Number:

Dates

Filing date:
08/06/2017
Grant date:
13/09/2023
EP Publication Date:
17/04/2019
PCT Publication Date:
14/12/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/09/2023
EP B1 Publication Date:
13/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/06/2024
Expiration date:
08/06/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/10/2023
 
 

Name:
Xencor, Inc.
Address:
465 North Halstead Street Suite 200, Pasadena, CA 91107, United States (US)

History of Owners

From:
06/09/2023
To:
13/10/2023

Name:
Xencor, Inc.
Address:
111 W. Lemon Avenue, Monrovia, CA 91016, United States (US)

Inventor

1

Name:
STONE, John H.
Address:
United States (US)

2

Name:
FOSTER, Paul
Address:
United States (US)

3

Name:
ZACK, Debra
Address:
United States (US)

4

Name:
PILLAI, Shiv
Address:
United States (US)

Priority

1

Priority Number:
201662347419 P
Priority Date:
08/06/2016
Priority Country:
United States (US)

2

Priority Number:
201662399896 P
Priority Date:
26/09/2016
Priority Country:
United States (US)

3

Priority Number:
201662421261 P
Priority Date:
12/11/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61P 37/06; A61K 39/00;

Publication

European Patent Bulletin

1

Issue number:
202337
Publication date:
13/09/2023
Description:
Grant (B1)

2

Issue number:
202340
Publication date:
04/10/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202346
Publication date:
15/11/2023
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages